Galectins distinctively regulate central monocyte and macrophage function

Cellular Immunology

Volumn 271, Issue 1, 2011, Pages 97-103

  Paclik, Daniela ^a   Werner, Lael ^a   Guckelberger, Olaf ^a   Wiedenmann, Bertram ^a   Sturm, Andreas ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Galectins; Inflammatory bowel disease; Macrophages; Monocytes; T cells

Indexed keywords

CYTOKINE; GALECTIN; GALECTIN 1; GALECTIN 2; GALECTIN 3; GALECTIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

APOPTOSIS; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; INTESTINE; MACROPHAGE; MACROPHAGE FUNCTION; MONOCYTE; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR UPREGULATION; SALMONELLA; SUPERNATANT; T LYMPHOCYTE ACTIVATION;

APOPTOSIS; BINDING, COMPETITIVE; CELL MOVEMENT; CELLS, CULTURED; CYTOKINES; FLOW CYTOMETRY; GALECTIN 1; GALECTIN 2; GALECTIN 3; GALECTIN 4; GALECTINS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; MACROPHAGES; MONOCYTES; PHAGOCYTOSIS; PROTEIN BINDING; SALMONELLA; T-LYMPHOCYTES;

SALMONELLA;

EID: 80052363945     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.06.003     Document Type: Article

References (43)

1. Mukhopadhyay S., Pluddemann A., Gordon S. Macrophage pattern recognition receptors in immunity, homeostasis and self tolerance. Target Pattern Recognition in Innate Immunity 2009, 653:1-14.
2. Schenk M., Mueller C. Adaptations of intestinal macrophages to an antigen-rich environment. Semin. Immunol. 2007, 19:84-93.
3. Chapuis F., Rosenzwajg M., Yagello M., Ekman M., Biberfeld P., Gluckman J.C. Differentiation of human dendritic cells from monocytes in vitro. Eur. J. Immunol. 1997, 27:431-441.
4. Randolph G.J., Luther T., Albrecht S., Magdolen V., Muller W.A. Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro. Blood 1998, 92:4167-4177.
5. Hume D.A. The mononuclear phagocyte system. Curr. Opin. Immunol. 2006, 18:49-53.
6. Hunter M., Wang Y.J., Eubank T., Baran C., Nana-Sinkam P., Marsh C. Survival of monocytes and macrophages and their role in health and disease. Front. Biosci. 2009, 14:4079-4102.
7. Hisamatsu T., Ogata H., Hibi T. Innate immunity in inflammatory bowel disease: state of the art. Curr. Opin. Gastroenterol. 2008, 24:448-454.
8. Zhou L., Braat H., Faber K.N., Dijkstra G., Peppelenbosch M.P. Monocytes and their pathophysiological role in Crohn's disease. Cell. Mol. Life Sci. 2009, 66:192-202.
9. Rabinovich G.A., Toscano M.A. Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat. Rev. Immunol. 2009, 9:338-352.
10. Yang R.Y., Rabinovich G.A., Liu F.T. Galectins: structure, function and therapeutic potential. Expert Rev. Mol. Med. 2008, 10:e17.
11. Cooper D.N., Barondes S.H. God must love galectins; he made so many of them. Glycobiology 1999, 9:979-984.
12. Liu F.T., Rabinovich G.A. Galectins as modulators of tumour progression. Nat. Rev. Cancer 2005, 5:29-41.
13. Brewer C.F., Miceli M.C., Baum L.G. Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions. Curr. Opin. Struct. Biol. 2002, 12:616-623.
14. Paclik D., Danese S., Berndt U., Wiedenmann B., Dignass A., Sturm A. Galectin-4 controls intestinal inflammation by selective regulation of peripheral and mucosal T cell apoptosis and cell cycle. PLoS ONE 2008, 3:e2629.
15. Paclik D., Wiedenmann B., Dignass A.U., Sturm A. Galectin-2 and galectin-4 modulate intestinal epithelial cell function and intestinal wound healing. Gastroenterology 2008, 134:A395.
16. Sturm A., Lensch M., Andre S., Kaltner H., Wiedenmann B., Rosewicz S., Dignass A.U., Gabius H.J. Human galectin-2: novel inducer of T cell apoptosis with distinct profile of caspase activation. J. Immunol. 2004, 173:3825-3837.
17. Paclik D., Berndt U., Guzy C., Dankof A., Danese S., Holzloehner P., Rosewicz S., Wiedenmann B., Wittig B.M., Dignass A.U., Sturm A. Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice. J. Mol. Med. 2007.
18. Sturm A., Itoh J., Jacobberger J.W., Fiocchi C. p53 negatively regulates intestinal immunity by delaying mucosal T cell cycling. J. Clin. Invest. 2002, 109:1481-1492.
19. Grabig A., Paclik D., Guzy C., Dankof A., Baumgart D.C., Erckenbrecht J., Raupach B., Sonnenborn U., Eckert J., Schumann R.R., Wiedenmann B., Dignass A.U., Sturm A. Escherichia coli strain Nissle 1917 ameliorates experimental colitis via toll-like receptor 2- and toll-like receptor 4-dependent pathways. Infect. Immun. 2006, 74:4075-4082.
20. Sanchez-Munoz F., Dominguez-Lopez A., Yamamoto-Furusho J.K. Role of cytokines in inflammatory bowel disease. World J. Gastroenterol. 2008, 14:4280-4288.
21. Sartor R.B., Muehlbauer M. Microbial host interactions in IBD: implications for pathogenesis and therapy. Curr. Gastroenterol. Rep. 2007, 9:497-507.
22. Lugering A., Schmidt M., Lugering N., Pauels H.G., Domschke W., Kucharzik T. Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology 2001, 121:1145-1157.
23. Ilarregui J.M., Bianco G.A., Toscano M.A., Rabinovich G.A. The coming of age of galectins as immunomodulatory agents: impact of these carbohydrate binding proteins in T cell physiology and chronic inflammatory disorders. Ann. Rheum. Dis. 2005, 64(Suppl. 4):96-103.
24. Toscano M.A., Ilarregui J.M., Bianco G.A., Campagna L., Croci D.O., Salatino M., Rabinovich G.A. Dissecting the pathophysiologic role of endogenous lectins: glycan-binding proteins with cytokine-like activity?. Cytokine Growth Factor Rev. 2007, 18:57-71.
25. Demetter P., Nagy N., Martin B., Mathieu A., Dumont P., Decaestecker C., Salmon I. The galectin family and digestive disease. J. Pathol. 2008, 215:1-12.
26. Santucci L., Fiorucci S., Rubinstein N., Mencarelli A., Palazzetti B., Federici B., Rabinovich G.A., Morelli A. Galectin-1 suppresses experimental colitis in mice. Gastroenterology 2003, 124:1381-1394.
27. Rabinovich G.A., Baum L.G., Tinari N., Paganelli R., Natoli C., Liu F.T., Iacobelli S. Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?. Trends Immunol. 2002, 23:313-320.
28. Rabinovich G.A., Toscano M.A., Ilarregui J.M., Rubinstein N. Shedding light on the immunomodulatory properties of galectins: novel regulators of innate and adaptive immune responses. Glycoconj. J. 2004, 19:565-573.
29. Liu F.T., Hsu D.K., Zuberi R.I., Kuwabara I., Chi E.Y., Henderson W.R. Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am. J. Pathol. 1995, 147:1016-1028.
30. MacKinnon A.C., Farnworth S.L., Hodkinson P.S., Henderson N.C., Atkinson K.M., Leffler H., Nilsson U.J., Haslett C., Forbes S.J., Sethi T. Regulation of alternative macrophage activation by galectin-3. J. Immunol. 2008, 180:2650-2658.
31. Kaufmann S.H.E., Schaible U.E. Antigen presentation and recognition in bacterial infections. Curr. Opin. Immunol. 2005, 17:79-87.
32. Chamuleau M.E.D., Ossenkoppele G.J., van de Loosdrecht A.A. MHC class II molecules in tumour immunology: prognostic marker and target for immune modulation. Immunobiology 2006, 211:619-625.
33. Barrionuevo P., Beigier-Bompadre M., Ilarregui J.M., Toscano M.A., Bianco G.A., Isturiz M.A., Rabinovich G.A. A novel function for galectin-1 at the crossroad of innate and adaptive immunity: galectin-1 regulates monocyte/macrophage physiology through a nonapoptotic ERK-dependent pathway. J. Immunol. 2007, 178:436-445.
34. Gordon S., Martinez F.O. Alternative activation of macrophages: mechanism and functions. Immunity 2010, 32:593-604.
35. Sano H., Hsu D.K., Apgar J.R., Yu L., Sharma B.B., Kuwabara I., Izui S., Liu F.T. Critical role of galectin-3 in phagocytosis by macrophages. J. Clin. Invest. 2003, 112:389-397.
36. Mahnke K., Bedke T., Enk A.H. Regulatory conversation between antigen presenting cells and regulatory T cells enhance immune suppression. Cell Immunol. 2007, 250:1-13.
37. McAlindon M.E., Gray T., Galvin A., Sewell H.F., Podolsky D.K., Mahida Y.R. Differential lamina propria cell migration via basement membrane pores of inflammatory bowel disease mucosa. Gastroenterology 1998, 115:841-848.
38. Delbrouck C., Doyen I., Belot N., Decaestecker C., Ghanooni R., de Lavareille A., Kaltner H., Choufani G., Danguy A., Vandenhoven G., Gabius H.J., Hassid S., Kiss R. Galectin-1 is overexpressed in nasal polyps under budesonide and inhibits eosinophil migration. Lab. Invest. 2002, 82:147-158.
39. Malik R.K.J., Ghurye R.R., Lawrence-Watt D.J., Stewart H.J.S. Galectin-1 stimulates monocyte chemotaxis via the p44/42 MAP kinase pathway and a pertussis toxin-sensitive pathway. Glycobiology 2009, 19:1402-1407.
40. Gonzalez-Mejia M.E., Doseff A.I. Regulation of monocytes and macrophages cell fate. Front. Biosci. 2009, 14:2413-2431.
41. Allison A.C., Ferluga J., Prydz H., Schorlemmer H.U. Role of macrophage activation in chronic inflammation. Agents Actions 1978, 8:27-35.
42. Haruta I., Shibata N., Kato Y., Tanaka M., Kobayashi M., Oguma H., Shiratori K. Apoptosis inhibitor expressed by macrophages tempers autoimmune colitis and the risk of colitis-based carcinogenesis in TCR alpha(-/-) mice. J. Clin. Immunol. 2007, 27:549-556.
43. Lugering A., Lebiedz P., Koch S., Kucharzik T. Apoptosis as a therapeutic tool in IBD? Inflammatory bowel disease: genetics, barrier function. Immunol. Mech. Microb. Pathways 2006, 1072:62-77.